Weight-loss drugs suppress appetite and can cut 'food noise' - but deplete energy and worsen fatigue. Here's how Maria Shahid ...

Dr Wylie explains: ‘Weight loss of this magnitude is associated with a meaningful drop in the risk of type 2 diabetes, hypertension, sleep apnoea, and non-alcoholic fatty liver disease.

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

Factor’s meals are reportedly suitable for people trying to lose weight. It states that the meals contain an average of 600 calories . People can also choose lower calorie meals.